Clinical trial · Observational
Validity of Viome's Oral/throat Cancer Test
Validity of Viome's Oral/throat Cancer Test Among Patients with a Suspicion of Cancer
NCT06174428CI-TRIAL-00085220recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A total of at least 1,000 participants with suspicion of cancer including at least 107 subjects who will be diagnosed with OSCC or OPSCC will be enrolled from either primary or secondary care centers in the U.S. Clinicians will use Viome collection kits to collect saliva samples from eligible patients.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Oral and Throat Cancer | — | UNRESOLVED | — |
| Oral Squamous Cell Carcinoma | Oral Cavity Squamous Cell Carcinoma | ALIAS | 0.90 |
| Oropharyngeal Squamous Cell Carcinoma | Oropharyngeal Squamous Cell Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Oral/Throat cancer test | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- label
- Oral Squamous Cell Carcinoma (OSCC)
- description
- OSCC case cohort will consist of patients with Oral Squamous Cell Carcinoma (all stages, locations), recruited from either primary or secondary care.
- interventionNames
- Device: Oral/Throat cancer test
- label
- Oropharyngeal Squamous Cell Carcinoma (OPSCC)
- description
- OPSCC case cohort will consist of patients with Oral Squamous Cell Carcinoma (all stages, locations), recruited from either primary or secondary care.
- interventionNames
- Device: Oral/Throat cancer test
- label
- Cancer-free
- description
- Participants will be recruited following clinical adjudication with self-reported confirmation of no cancer and from primary and secondary care facilities.
- interventionNames
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Signed and dated informed consent prior to any study-specific procedures are performed * Willing and able to follow the study instructions, as described in the recruitment letter * Adults (18 years old or older) * Suspicion of OSCC or OPSCC on clinical presentation by a clinician Exclusion Criteria: * Pregnancy * Use of fertility enhancing medications
References
Publications (0)
Data not yet available
No reference posted for this study.